Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib to Prevent Recurrence of Superficial Bladder Cancer
NCT00006124Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2000
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in bladder cancer, sponsored by National Cancer Institute. Started Jun 2000; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00006124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006124.